Clarifai

Critical infrastructure underpins modern life—power grids, healthcare systems, manufacturing plants, and transportation networks that keep our world running. Yet these cyber-physical systems face escalating threats that can disrupt essential services and endanger public safety. Claroty exists to secure these vital connections, empowering organizations across industrial, healthcare, public sector, and commercial environments to protect their Extended Internet of Things (XIoT) assets. The company's platform delivers comprehensive visibility, threat detection, and vulnerability management, ensuring that operational technology, healthcare devices, and enterprise IoT remain resilient against cyber attacks. As digital transformation accelerates, the convergence of IT and operational technology creates new vulnerabilities that traditional security tools cannot address. Claroty's purpose-built solutions provide deep protocol coverage and AI-driven analytics to detect both known and unknown threats before they cause damage. By securing mission-critical infrastructure across healthcare delivery, manufacturing, energy, and government operations, Claroty enables life to continue uninterrupted—protecting not just systems, but the people and communities who depend on them every single day.

Founded in 2011, Claritas Rx emerged from a critical gap in the specialty pharmaceutical industry: manufacturers lacked visibility into what happened to patients after prescriptions left their offices. In complex specialty networks where medications could travel through specialty distributors, pharmacies, and hub services, biopharma companies were essentially flying blind - unable to see the real-world barriers that prevented patients from starting or staying on life-changing treatments. Our founders realized that without this visibility, manufacturers couldn't optimize patient access, improve adherence, or truly understand therapy performance in the real world. Today, Claritas Rx has grown from a small channel data consultancy into a pioneering healthcare technology company that illuminates the complete patient journey. Our intelligent Claritas Rx Ascend platform unifies fragmented healthcare data from specialty pharmacies, distributors, and hubs, then applies AI and predictive modeling to identify barriers before they disrupt care. With 95% patient match accuracy and the ability to increase fill rates by 20% in complex cases, we've transformed from data aggregators to trusted partners who help rare disease and specialty brands remove access barriers - ensuring patients not only start therapy but stay on it. From our headquarters in South San Francisco, our team of patient journey experts continues pushing the boundaries of what's possible in specialty analytics, because we believe progress means every patient journey counts.

At Clarivate, we are united by a shared belief that human ingenuity has the power to solve the world's most complex challenges. Our global team of researchers, data scientists, and industry experts work together to provide transformative intelligence that accelerates innovation across academia, healthcare, and intellectual property. We foster a culture of collaboration where diverse perspectives are valued and every voice matters—ensuring we deliver insights our customers can trust. We believe in pushing boundaries while maintaining integrity and accountability in everything we do. Our team members thrive in an environment that encourages continuous learning, creative problem-solving, and meaningful impact—from helping researchers advance scientific discovery to supporting life sciences companies develop life-saving treatments. We celebrate our collective achievements through team-building activities, community volunteering, and recognition programs that honor both individual contributions and collaborative success.

Clario is a leading healthcare research and technology company that generates high-quality clinical evidence for pharmaceutical, biotechnology, and medical device partners. Formerly known as ERT and Bioclinica, Clario brings over 50 years of expertise to clinical trial management. The company fuses deep scientific knowledge with global scale to deliver the broadest endpoint technology platform available. Clario has supported nearly 900 regulatory approvals across 19,000 studies spanning almost 600 indications, demonstrating a proven track record of accelerating drug development and reducing trial risk. Clario's comprehensive solutions span cardiac safety, electronic clinical outcome assessments (eCOA), medical imaging, precision motion, respiratory endpoints, and clinical adjudication. The company supports decentralized, hybrid, and site-based trials with advanced cloud-native technologies and AI-powered tools. With a presence in more than 80,000 sites worldwide, Clario's science-informed approach ensures the richest evidence possible for life-changing therapies. Their mission is to transform lives by unlocking better evidence, uniting clinical science, innovative technology, and global expertise to bring new treatments to patients faster.

In 2023, Cloover's founders recognized a critical bottleneck in Europe's energy transition: renewable energy installers were struggling with fragmented operations, limited access to financing, and inefficient workflows that slowed down the adoption of clean energy solutions. They built Cloover as the AI-powered operating system for renewable energy installers - an integrated platform that seamlessly combines software, embedded financing, and energy management into one unified solution. By positioning itself as the 'Shopify for energy,' Cloover transforms how installers run their businesses, enabling them to offer flexible financing options to homeowners while streamlining their entire operations from lead to installation. The company's mission extends beyond software - they're building the digital nervous system for distributed energy, working to deliver energy independence to 1 billion people. With over $1.2 billion in financing commitments and $22 million in Series A funding, Cloover is scaling rapidly across Europe, dismantling silos between stakeholders and accelerating the continent's journey toward net-zero emissions through technology that makes renewable energy accessible, affordable, and hassle-free for everyone.

At Trafilea, we believe culture drives everything we build. Our remote-first team of 400+ talents across 19 countries thrives on ownership, speed, and continuous learning. We don't just work together - we challenge each other to think bigger and go further. Every team member contributes to our success, with real autonomy to make decisions and drive impact. We combine data-driven decision making with human connection, celebrating wins together and supporting each other through challenges. Our core values aren't just words - they're how we operate daily. From 'Spread Love' to 'Always Growing,' we live these principles whether we're collaborating across time zones or gathering for our annual leadership retreats. We're passionate marketers, tech innovators, and ambitious doers united by one purpose: changing people's lives through transformative brands.